Arcturus Therapeutics Holdings, Inc. (ARCT)
12.16
+0.09
(+0.75%)
USD |
NASDAQ |
Oct 29, 16:00
12.15
-0.01
(-0.08%)
After-Hours: 20:00
Arcturus Therapeutics Holdings Market Cap : 345.62M for Oct. 29, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 28, 2026 | 343.07M |
| October 27, 2026 | 319.19M |
| October 26, 2026 | 281.67M |
| October 23, 2026 | 279.68M |
| October 22, 2026 | 304.98M |
| October 21, 2026 | 314.64M |
| October 20, 2026 | 312.08M |
| October 19, 2026 | 296.17M |
| October 16, 2026 | 293.89M |
| October 15, 2026 | 320.33M |
| October 14, 2026 | 316.06M |
| October 13, 2026 | 341.93M |
| October 12, 2026 | 358.41M |
| October 09, 2026 | 390.53M |
| October 08, 2026 | 365.80M |
| October 07, 2026 | 362.82M |
| October 06, 2026 | 369.50M |
| October 05, 2026 | 416.68M |
| October 02, 2026 | 370.35M |
| October 01, 2026 | 375.47M |
| September 30, 2026 | 389.11M |
| September 29, 2026 | 389.40M |
| September 28, 2026 | 411.00M |
| September 25, 2026 | 393.66M |
| September 24, 2026 | 401.33M |
| Date | Value |
|---|---|
| September 23, 2026 | 378.03M |
| September 22, 2026 | 408.72M |
| September 21, 2026 | 417.53M |
| September 18, 2026 | 455.62M |
| September 17, 2026 | 481.20M |
| September 16, 2026 | 443.40M |
| September 15, 2026 | 450.22M |
| September 14, 2026 | 434.59M |
| September 11, 2026 | 418.67M |
| September 10, 2026 | 397.35M |
| September 09, 2026 | 418.96M |
| September 08, 2026 | 444.25M |
| September 04, 2026 | 449.65M |
| September 03, 2026 | 442.26M |
| September 02, 2026 | 475.80M |
| September 01, 2026 | 461.16M |
| August 31, 2026 | 419.52M |
| August 28, 2026 | 431.75M |
| August 27, 2026 | 459.60M |
| August 26, 2026 | 449.94M |
| August 25, 2026 | 438.85M |
| August 24, 2026 | 407.59M |
| August 21, 2026 | 382.29M |
| August 20, 2026 | 312.37M |
| August 19, 2026 | 292.19M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.573B |
| Emergent BioSolutions, Inc. | 370.64M |
| Exelixis, Inc. | 16.49B |
| Ionis Pharmaceuticals, Inc. | 7.354B |
| United Therapeutics Corp. | 25.31B |
Market Cap Related Metrics
| PS Ratio | 18.21 |
| PEG Ratio | -0.0749 |
| Price to Book Value | 2.012 |
| Price | 12.16 |
| Earnings Yield | -27.26% |
| PEGY Ratio | -0.0749 |